Seeking to outpace the market, investors engage in the art of selecting individual stocks. The right picks can play a pivotal role in boosting your wealth.
The price of Adient plc (NYSE: ADNT) closed at $28.11 in the last session, down -1.85% from day before closing price of $28.64. In other words, the price has decreased by -$1.85 from its previous closing price. On the day, 1.15 million shares were traded. ADNT stock price reached its highest trading level at $28.925 during the session, while it also had its lowest trading level at $27.98.
Ratios:
We take a closer look at ADNT’s different ratios to gain a better understanding of the stock. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 2.59 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 6.04. For the most recent quarter (mrq), Quick Ratio is recorded 0.91 and its Current Ratio is at 1.15. In the meantime, Its Debt-to-Equity ratio is 1.22 whereas as Long-Term Debt/Eq ratio is at 1.12.
Upgrades & Downgrades
In addition, analysts’ ratings and any changes thereto give investors an idea of the stock’s future direction. In the most recent recommendation for the company, Barclays on April 10, 2024, Downgraded its rating to Equal Weight and sets its target price to $37 from $41 previously.
On September 13, 2023, UBS started tracking the stock assigning a Neutral rating and target price of $43.
Insider Transactions:
An investor can also benefit from insider trades by learning what management is thinking about the future direction of stock prices. A recent insider transaction in this stock occurred on Feb 20 ’24 when Berthelin Michel Pierre Rose sold 1,300 shares for $34.22 per share. The transaction valued at 44,486 led to the insider holds 92,662 shares of the business.
Tiltmann Heather M sold 10,000 shares of ADNT for $336,800 on Feb 14 ’24. The EVP, CLO, CHRO & Secretary now owns 55,669 shares after completing the transaction at $33.68 per share. On Feb 12 ’24, another insider, Conklin James, who serves as the EVP, Americas of the company, sold 3,492 shares for $35.00 each. As a result, the insider received 122,220 and left with 31,542 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ADNT now has a Market Capitalization of 2564922368 and an Enterprise Value of 4753921024. As of this moment, Adient’s Price-to-Earnings (P/E) ratio for their current fiscal year is 12.50, and their Forward P/E ratio for the next fiscal year is 6.97. The expected Price-to-Earnings-to-Growth (PEG) calculation for the next 5 years is 0.29. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.17 while its Price-to-Book (P/B) ratio in mrq is 1.12. Its current Enterprise Value per Revenue stands at 0.31 whereas that against EBITDA is 6.033.
Stock Price History:
Over the past 52 weeks, ADNT has reached a high of $46.51, while it has fallen to a 52-week low of $28.35. The 50-Day Moving Average of the stock is -15.20%, while the 200-Day Moving Average is calculated to be -21.45%.
Shares Statistics:
According to the various share statistics, ADNT traded on average about 1.09M shares per day over the past 3-months and 1151850 shares per day over the past 10 days. A total of 93.70M shares are outstanding, with a floating share count of 89.67M. Insiders hold about 1.73% of the company’s shares, while institutions hold 93.19% stake in the company. Shares short for ADNT as of 1711584000 were 5265903 with a Short Ratio of 4.84, compared to 1709164800 on 5320002. Therefore, it implies a Short% of Shares Outstanding of 5265903 and a Short% of Float of 8.1499994.
Earnings Estimates
The market rating for Adient plc (ADNT) is a result of the insights provided by Advent Technologies Holdings, I analysts actively involved in the assessment.The consensus estimate for the next quarter is $2.44, with high estimates of $28.11 and low estimates of $6.18.
Analysts are recommending an EPS of between $Consumer Cyclical and $Industrials for the fiscal current year, implying an average EPS of $Healthcare.
